## COO: The Cooper Companies, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($72.56)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Invesco Ltd. Sells 100,819 Shares of The Cooper Companies, Inc. $COO**
- Source: MarketBeat | 20251206T113440 | Somewhat-Bullish | Relevance: 99%
-  Invesco Ltd. reduced its stake in The Cooper Companies, Inc. by 2.1% in the second quarter, selling 100,819 shares and now owning 4,623,938 shares valued at $329 million. Other institutional investors also adjusted their positions in COO, while a director of Cooper Companies, Lawrence Erik Kurzius, purchased 2,000 shares. The company recently announced a $2.00 billion share repurchase program and has received mostly positive ratings from analysts, with an average price target of $90.31.

**2. Cooper Companies price target raised to $88 from $72 at Citi**
- Source: TipRanks | 20251208T140823 | Bullish | Relevance: 98%
- Citi has raised its price target for Cooper Companies (COO) to $88 from $72, while maintaining a Neutral rating on the shares. This adjustment follows the company's better-than-expected fiscal Q4 results, which broke a trend of previous misses. The upgrade reflects a positive outlook on Cooper Companies' recent financial performance.

**3. Cooper Companies (NASDAQ:COO) Price Target Raised to $78.00 at JPMorgan Chase & Co.**
- Source: MarketBeat | 20251206T155856 | Somewhat-Bullish | Relevance: 98%
-  JPMorgan Chase & Co. has raised its price target for Cooper Companies (NASDAQ:COO) from $66.00 to $78.00 while maintaining a "neutral" rating, indicating a potential 5.75% downside from the previous close. This adjustment follows Cooper's strong quarterly performance, exceeding EPS and revenue estimates, and its announcement of a $2.0 billion share buyback program. Despite the "neutral" rating from JPMorgan, the stock holds a consensus "Moderate Buy" rating among analysts with an average target price of $89.54.

**4. Why Cooper Companies (COO) Is Up 5.2% After Strategic Review, Buyback Completion And 2026 Outlook**
- Source: Simply Wall Street | 20251208T110823 | Somewhat-Bullish | Relevance: 98%
- CooperCompanies' stock (COO) rose 5.2% after reporting Q4 and full-year 2025 results, outlining a strategic review, completing a significant share buyback, and providing a 2026 outlook. The company's revenue increased, but net income and EPS were lower compared to the previous year, prompting an increased focus on portfolio optimization and capital allocation. This strategic review, along with a new share repurchase focus, aims to reinforce capital returns and support the narrative of improving profitability despite challenges in the contact lens market.

**5. Norges Bank Invests $35.06 Million in The Cooper Companies, Inc. $COO**
- Source: MarketBeat | 20251208T104621 | Somewhat-Bullish | Relevance: 98%
-  Norges Bank recently acquired a significant stake in The Cooper Companies, Inc. (NASDAQ:COO), purchasing 492,706 shares valued at approximately $35.06 million during the second quarter. This investment makes Norges Bank a substantial shareholder, owning about 0.25% of the company. The article also details other institutional investor activities, analyst ratings, and insider transactions related to Cooper Companies, highlighting a "Moderate Buy" consensus and a $90.31 average target price.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $88 | $72 | +22% |
| 2025-12-08 | Morgan Stanley | $83 | $76 | +9% |
| 2025-12-08 | Goldman Sachs | $71 | $64 | +11% |
| 2025-12-05 | Stifel | $95 | $85 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Neutral |
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |
| 2025-12-08 | Goldman Sachs | main | Sell |
| 2025-12-05 | Stifel | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.14M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-1.1%)
- Blackrock Inc.: 7.7% (-0.8%)
- Capital World Invest: 5.3% (+25.7%)
- T. Rowe Price Invest: 4.9% (+33.2%)
- State Street Corpora: 4.3% (-0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 10 raises (avg +14%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.87 indicates undervaluation relative to growth. Analyst sentiment positive (10 raises, avg +14%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.6B |
| Beta | 1.05 |
| 52W Range | $61.78 - $100.47 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.87 |
| Forward P/E | 15.8 |
| Current P/E | 17.3 |
| YoY Growth | 9.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.9% to -0.4% (+1.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Outperforming sector by 3.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.36% (CS: 52) | Neutral |
| RSI_14 | 59.7 | Neutral |
| MACD Histogram | 0.36 | Bullish |
| vs SMA20 | 1.043x | Above |
| vs SMA50 | 1.079x | Above |
| vs SMA200 | 1.043x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $78.04
- **Stop Loss:** $72.56 (7.0% risk)
- **Target:** $83.52 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 91
- **Position Value:** $7,101.64
- **Portfolio %:** 7.10%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-03-05 (Est: $1.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.11 | $1.15 | +3.3% |
| 2025Q3 | $1.07 | $1.10 | +3.0% |
| 2025Q2 | $0.93 | $0.96 | +3.3% |
| 2025Q1 | $0.91 | $0.92 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*